Related references
Note: Only part of the references are listed.A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment
Yangqing Zhang et al.
ACTA BIOMATERIALIA (2010)
Transferrin-conjugated nanoparticles of Poly(lactide)-D-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier
Chee Wee Gan et al.
BIOMATERIALS (2010)
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
Svetlana Gelperina et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Overcoming the formulation obstacles towards targeted chemotherapy:: In vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles
Nir Debotton et al.
JOURNAL OF CONTROLLED RELEASE (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Active targeting of brain tumors using nanocarriers
Arnaud Beduneau et al.
BIOMATERIALS (2007)
Chemotherapy of brain turnour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles:: Revisiting the role of surfactants
B. Petri et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain
K. Michaelis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Development of a novel formulation containing poly(D,L-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir
S Duvvuri et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating
JA MacKay et al.
BRAIN RESEARCH (2005)
Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions
F Roux et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain
J Kreuter
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2004)
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
DJ Begley
PHARMACOLOGY & THERAPEUTICS (2004)
Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease
J Ribalta et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2003)
The expression of native and oxidized LDL receptors in brain microvessels is specifically enhanced by astrocytes-derived soluble factor(s)
M Lucarelli et al.
FEBS LETTERS (2002)
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier
J Kreuter et al.
JOURNAL OF DRUG TARGETING (2002)
Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat
P Calvo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma
SE Gelperina et al.
TOXICOLOGY LETTERS (2002)
PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases
P Calvo et al.
JOURNAL OF NEUROSCIENCE METHODS (2001)
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs
GM Zentner et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Nanoparticulate systems for brain delivery of drugs
J Kreuter
ADVANCED DRUG DELIVERY REVIEWS (2001)
Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats
EM Davidson et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2001)
Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system
A Friese et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables
RA Jain et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Share Paper
